FOLH1 and pachyonychia congenita: In the data presented here, we detected PSMA-expressing CTCs in two patients but none in the patient with treatment-emergent neuroendocrine PC, where we detected three CTCs expressing KRT and neuroendocrine markers, but no prostate-specific markers.